Pulm Pharmacol Ther

Hyperbaric oxygen therapy as an immunomodulatory intervention in COVID-19-induced ARDS: Exploring clinical outcomes and transcriptomic signatures in a randomised controlled trial.

Kjellberg A, Zhao A, Lussier A, ..., Rodriguez-Wallberg KA, Lindholm P

Pulm Pharmacol Ther 87 (-) 102330 [2024-12-00; online 2024-10-10]

Endothelin Antagonism and Sodium Glucose Co-transporter 2 Inhibition A Potential Combination Therapeutic Strategy for COVID-19.

Fisk M, Althage M, Moosmang S, ..., Ambery P, Cheriyan J

Pulm Pharmacol Ther - (-) 102035 [2021-04-29; online 2021-04-29]

Type: Review